UBS Group’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-291,642
Closed -$24.8M 7990
2020
Q3
$24.8M Buy
291,642
+223,794
+330% +$19M 0.01% 813
2020
Q2
$2.41M Buy
67,848
+27,647
+69% +$980K ﹤0.01% 2141
2020
Q1
$542K Sell
40,201
-132,778
-77% -$1.79M ﹤0.01% 3144
2019
Q4
$3.66M Sell
172,979
-239,682
-58% -$5.07M ﹤0.01% 2249
2019
Q3
$5.47M Buy
412,661
+231,639
+128% +$3.07M ﹤0.01% 1783
2019
Q2
$2.51M Buy
181,022
+174,477
+2,666% +$2.42M ﹤0.01% 2341
2019
Q1
$125K Sell
6,545
-105,608
-94% -$2.02M ﹤0.01% 4145
2018
Q4
$1.6M Buy
112,153
+58,927
+111% +$841K ﹤0.01% 2621
2018
Q3
$1.11M Buy
53,226
+43,775
+463% +$912K ﹤0.01% 3061
2018
Q2
$224K Sell
9,451
-179,779
-95% -$4.26M ﹤0.01% 4020
2018
Q1
$2.77M Sell
189,230
-170,740
-47% -$2.49M ﹤0.01% 2303
2017
Q4
$5.82M Buy
359,970
+45,495
+14% +$735K ﹤0.01% 1721
2017
Q3
$4.4M Buy
314,475
+244,311
+348% +$3.42M ﹤0.01% 1837
2017
Q2
$620K Buy
70,164
+66,464
+1,796% +$587K ﹤0.01% 3223
2017
Q1
$24K Buy
3,700
+1,000
+37% +$6.49K ﹤0.01% 5117
2016
Q4
$10K Hold
2,700
﹤0.01% 5981
2016
Q3
$9K Sell
2,700
-21,292
-89% -$71K ﹤0.01% 5947
2016
Q2
$56K Buy
23,992
+11,903
+98% +$27.8K ﹤0.01% 4592
2016
Q1
$30K Sell
12,089
-9,574
-44% -$23.8K ﹤0.01% 5086
2015
Q4
$66K Buy
21,663
+10,413
+93% +$31.7K ﹤0.01% 4539
2015
Q3
$19K Sell
11,250
-10,640
-49% -$18K ﹤0.01% 5500
2015
Q2
$89K Hold
21,890
﹤0.01% 4369
2015
Q1
$84K Sell
21,890
-7,190
-25% -$27.6K ﹤0.01% 4294
2014
Q4
$140K Buy
+29,080
New +$140K ﹤0.01% 3991